Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis.

Sen, Monokesh K; Hossain, Md Jakir; Mahns, David A; Brew, Bruce J

Sen, Monokesh K; Hossain, Md Jakir; Mahns, David A; Brew, Bruce J.

Afiliação

Sen MK; School of Medicine, Western Sydney University, Penrith, NSW, Australia.
Hossain MJ; Peter Duncan Neuroscience Research Unit, St Vincent's Centre for Applied Medical Research, Darlinghurst, Sydney, 2010, Australia.
Mahns DA; Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2006, Australia.
Brew BJ; School of Biomedical Sciences, UNSW Sydney, Sydney, NSW, 2052, Australia.

J Neurol ; 270(4): 1908-1930, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36520240

Assuntos

Esclerose Múltipla; Humanos; Prognóstico; Filamentos Intermediários; Biomarcadores; Proteínas de Neurofilamentos; Progressão da Doença

Palavras-chave

Assay standardisation; Axonal injury; Blood-based biomarker; Cerebrospinal fluid; MS prognosis; Neurodegeneration; Neurofilament; Neuroinflammation; Treatment response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google